EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer

Shuyu Liu, Jiajun Ma, You Li, Junyi Yang, Dajun Zhang, Nan Cai, Zehui Tan, Xin Zhai

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Shuyu Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Drug Design, Antineoplastic Agents, Protein Kinase Inhibitors. Die Arbeit nennt 26 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent research certified that HGK, as an upstream regulator of the MAPK/ERK signaling pathway, represents a promising target for lung cancer therapy. Herein, in pursuit of novel HGK inhibitors, a series of 1-aryl-3-hydroxypyrrolidine derivatives were designed and synthesized based on the hit compound Z1, which was obtained via high-throughput screening. Through comprehensive biological evaluation, Z7 was identified as the optimal compound with potent enzymatic (HGK IC50 = 0.047 μM) and cellular activities (H460 IC50 = 1.42 μM). Notably, Z7 also demonstrated marked inhibition against HPK1 (IC50 = 0.065 μM) in selectivity assessment, positioning it as a dual HGK/HPK1 inhibitor. Moreover, Z7 exhibited favorable selectivity across a panel of 80 kinases and pronounced in vivo anti-lung cancer efficacy (TGI = 68.94% at 20 mg/kg dosage) in H460 xenograft models. Overall, our findings suggest that dual targeting of HGK and HPK1 represents a viable therapeutic strategy for lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDrug DesignAntineoplastic AgentsProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyrrolidinesHumansStructure-Activity RelationshipAnimalsDrug Screening Assays, AntitumorMolecular StructureCell ProliferationDose-Response Relationship, DrugMiceCell Line, TumorMice, NudeNeoplasms, ExperimentalIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

Dual inhibitorsHGKHPK1Lung cancerNovel skeleton

Substanzen

Antineoplastic AgentsProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyrrolidinesMKNK1 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • School of Pharmacy, Shenyang Medical College, Shenyang 110034, China.
  • School of Pharmacy, Shenyang Medical College, Shenyang 110034, China. Electronic address: ladycainan@126.com.
  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: tanzehui_syphu@163.com.
  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: zhaixin_syphu@126.com.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Ma, J., Li, Y., Yang, J., Zhang, D., Cai, N., Tan, Z., & Zhai, X. (2026). Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110473

Vancouver

Liu S, Ma J, Li Y, Yang J, Zhang D, Cai N, et al. Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110473

BibTeX
@article{Liu2026,
  author = {Liu, Shuyu and Ma, Jiajun and Li, You and Yang, Junyi and Zhang, Dajun and Cai, Nan and Tan, Zehui and Zhai, Xin},
  title = {Design, synthesis, and biological evaluation of novel 1-aryl-3-hydroxypyrrolidine derivatives as dual HGK/HPK1 inhibitors with therapeutic potential for lung cancer},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110473}
}
Kostenlos starten →